• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD
Asia-Pacific In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2015 Product Image

Asia-Pacific In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2015

  • ID: 1146845
  • December 2009
  • Region: Asia
  • 164 Pages
  • Global Markets Direct

FEATURED COMPANIES

  • Abbott Laboratories
  • bioMerieux S.A.
  • Digene Corporation
  • F. Hoffmann-La Roche Ltd.
  • Hologic, Inc.
  • Qiagen N.V.
  • MORE

This report is an essential source for in-depth information and data relating to Asia Pacific In vitro diagnostics market. It also offers detailed and comprehensive coverage of market revenue, distribution and company share information; and the latest news, financial deals and pipeline products information of each of the key sub-segments of the in vitro diagnostics market in Asia Pacific

Scope

- The report provides information on the Asia Pacific in vitro diagnostics market, broken down into detailed categories and segments including In Vitro Diagnostics Devices, Clinical Chemistry Test Reagents, Immunochemistry Test Reagents, Blood Test Reagents, Microbiology Test Reagents, Infectious Immunology Test Reagents, Genetic Test Reagents, Self Testing, and Instruments.
- Market shares of all the key competitors including F. Hoffmann-La Roche Ltd., Abbott Laboratories, Beckman Coulter, Inc., and Siemens Medical Solutions, amongst others.
- Key pipeline products that are set to shape the market, broken down by sector.
- Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis.
- Healthcare structure, READ MORE >

Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abbott Laboratories
  • bioMerieux S.A.
  • Digene Corporation
  • F. Hoffmann-La Roche Ltd.
  • Hologic, Inc.
  • Qiagen N.V.
  • MORE

1 TOC
1.1 List of Tables
1.2 List of Figures

2 Introduction
2.1 What Is This Report About?

3 Definitions of Markets Covered in the Report
3.1 In Vitro Diagnostics
3.2 Clinical Chemistry
3.3 Genetic Testing
3.4 Haematology
3.5 Histology And Cytology
3.6 Immuno Chemistry
3.7 Infectious Immunology
3.8 Microbiology Culture

4 In Vitro Diagnostics in Asia-Pacific
4.1 In Vitro Diagnostics, Asia-Pacific, Overall Revenue ($ mn), 2000-2015
4.2 In Vitro Diagnostics, Asia-Pacific, Company share (2007-2008)

5 In Vitro Diagnostics In Japan
5.1 In Vitro Diagnostics, Japan, Overall Revenue ($ mn), 2000-2015
5.2 In Vitro Diagnostics, Japan, Distribution Share (2007-2008)
5.2.1 Clinical Chemistry Distribution Share (2007-2008)
5.2.2 Genetic Testing Distribution Share (2007-2008)
5.2.3 Haematology Distribution Share (2007-2008)
5.2.4 Histology And Cytology Distribution Share (2007-2008)
5.2.5 Immuno Chemistry Distribution Share (2007-2008)
5.2.6 Infectious Immunology Distribution Share (2007-2008)
5.2.7 Microbiology Culture Distribution Share (2007-2008)
5.3 In Vitro Diagnostics, Japan, Company Share (2007-2008)
5.3.1 In Vitro Diagnostics, Japan, Company Share (2007-2008)
5.3.2 Clinical Chemistry, Japan, Company Share (2007-2008)
5.3.3 Genetic Testing, Japan, Company Share (2007-2008)
5.3.4 Haematology, Japan, Company Share (2007-2008)
5.3.5 Histology And Cytology, Japan, Company Share (2007-2008)
5.3.6 Immuno Chemistry, Japan, Company Share (2007-2008)
5.3.7 Infectious Immunology, Japan, Company Share (2007-2008)
5.3.8 Microbiology Culture, Japan, Company Share (2007-2008)

6 In Vitro Diagnostics In Australia
6.1 In Vitro Diagnostics, Australia, Overall Revenue ($ mn), 2000-2015
6.2 In Vitro Diagnostics, Australia, Distribution Share (2007-2008)
6.2.1 Clinical Chemistry Distribution Share (2007-2008)
6.2.2 Genetic Testing Distribution Share (2007-2008)
6.2.3 Haematology Distribution Share (2007-2008)
6.2.4 Histology And Cytology Distribution Share (2007-2008)
6.2.5 Immuno Chemistry Distribution Share (2007-2008)
6.2.6 Infectious Immunology Distribution Share (2007-2008)
6.2.7 Microbiology Culture Distribution Share (2007-2008)
6.3 In Vitro Diagnostics, Australia, Company Share (2007-2008)
6.3.1 In Vitro Diagnostics, Australia, Company Share (2007-2008)
6.3.2 Clinical Chemistry, Australia, Company Share (2007-2008)
6.3.3 Genetic Testing, Australia, Company Share (2007-2008)
6.3.4 Haematology, Australia, Company Share (2007-2008)
6.3.5 Histology And Cytology, Australia, Company Share (2007-2008)
6.3.6 Immuno Chemistry, Australia, Company Share (2007-2008)
6.3.7 Infectious Immunology, Australia, Company Share (2007-2008)
6.3.8 Microbiology Culture, Australia, Company Share (2007-2008)

7 In Vitro Diagnostics In China
7.1 In Vitro Diagnostics, China, Overall Revenue ($ mn), 2000-2015
7.2 In Vitro Diagnostics, China, Distribution Share (2007-2008)
7.2.1 Clinical Chemistry Distribution Share (2007-2008)
7.2.2 Genetic Testing Distribution Share (2007-2008)
7.2.3 Haematology Distribution Share (2007-2008)
7.2.4 Histology And Cytology Distribution Share (2007-2008)
7.2.5 Immuno Chemistry Distribution Share (2007-2008)
7.2.6 Infectious Immunology Distribution Share (2007-2008)
7.2.7 Microbiology Culture Distribution Share (2007-2008)
7.3 In Vitro Diagnostics, China, Company Share (2007-2008)
7.3.1 In Vitro Diagnostics, China, Company Share (2007-2008)
7.3.2 Clinical Chemistry, China, Company Share (2007-2008)
7.3.3 Genetic Testing, China, Company Share (2007-2008)
7.3.4 Haematology, China, Company Share (2007-2008)
7.3.5 Histology And Cytology, China, Company Share (2007-2008)
7.3.6 Immuno Chemistry, China, Company Share (2007-2008)
7.3.7 Infectious Immunology, China, Company Share (2007-2008)
7.3.8 Microbiology Culture, China, Company Share (2007-2008)

8 In Vitro Diagnostics In India
8.1 In Vitro Diagnostics, India, Overall Revenue ($ mn), 2000-2015
8.2 In Vitro Diagnostics, India, Distribution Share (2007-2008)
8.2.1 Clinical Chemistry Distribution Share (2007-2008)
8.2.2 Genetic Testing Distribution Share (2007-2008)
8.2.3 Haematology Distribution Share (2007-2008)
8.2.4 Histology And Cytology Distribution Share (2007-2008)
8.2.5 Immuno Chemistry Distribution Share (2007-2008)
8.2.6 Infectious Immunology Distribution Share (2007-2008)
8.2.7 Microbiology Culture Distribution Share (2007-2008)
8.3 In Vitro Diagnostics, India, Company Share (2007-2008)
8.3.1 In Vitro Diagnostics, India, Company Share (2007-2008)
8.3.2 Clinical Chemistry, India, Company Share (2007-2008)
8.3.3 Genetic Testing, India, Company Share (2007-2008)
8.3.4 Haematology, India, Company Share (2007-2008)
8.3.5 Histology And Cytology, India, Company Share (2007-2008)
8.3.6 Immuno Chemistry, India, Company Share (2007-2008)
8.3.7 Infectious Immunology, India, Company Share (2007-2008)
8.3.8 Microbiology Culture, India, Company Share (2007-2008)

9 Overview of Key Companies in Asia-Pacific In Vitro Diagnostics Market
9.1 Sysmex Corporation
9.1.1 Company Overview
9.1.2 Sysmex Corporation Pipeline Products
9.2 Siemens Healthcare
9.2.1 Company Overview
9.3 Qiagen N.V
9.3.1 Company Overview
9.3.2 Qiagen N.V. Pipeline Products
9.4 Phadia AB
9.4.1 Company Overview
9.4.2 Phadia AB Pipeline Products
9.5 Ortho-Clinical Diagnostics Inc
9.5.1 Company Overview
9.5.2 Ortho-Clinical Diagnostics Inc. Pipeline Products
9.6 Mindray Medical International Limited
9.6.1 Company Overview
9.6.2 Mindray Medical International Limited Pipeline Products
9.7 Hologic, Inc
9.7.1 Company Overview
9.7.2 Hologic, Inc. Pipeline Products
9.8 Gen-Probe Incorporated
9.8.1 Company Overview
9.8.2 Gen-Probe Incorporated Pipeline Products
9.9 F. Hoffmann-La Roche Ltd
9.9.1 Company Overview
9.10 Digene Corporation
9.10.1 Company Overview
9.11 DiaSorin S.p.A
9.11.1 Company Overview
9.11.2 DiaSorin S.p.A Pipeline Products
9.12 Dade Behring Holdings, Inc
9.12.1 Company Overview
9.13 Bio-Rad Laboratories, Inc
9.13.1 Company Overview
9.14 bioMerieux S.A
9.14.1 Company Overview
9.14.2 Biomerieux Sa Pipeline Products
9.15 Becton, Dickinson and Company
9.15.1 Company Overview
9.15.2 Becton, Dickinson and Company Pipeline Products
9.16 Beckman Coulter, Inc
9.16.1 Company Overview
9.16.2 Beckman Coulter, Inc. Pipeline Products
9.17 Abbott Laboratories
9.17.1 Company Overview
9.17.2 Abbott Laboratories Pipeline Products
9.18 Eiken Chemical Co.,Ltd
9.18.1 Company Overview
9.18.2 Eiken Chemical Co.,Ltd. Pipeline Products
9.19 Advanced Life Science Institute, Inc
9.19.1 Company Overview

10 Financial Deals Landscape
10.1 Acquisition
10.1.1 Metropolis Health Services Plans To Acquire Diagnostic Labs
10.1.2 PerkinElmer Completes Acquisition Of Sym-Bio LifeScience
10.1.3 PerkinElmer Acquires Surendra Genetic Labs
10.1.4 Beckman Coulter Completes Acquisition Of Olympus-DS From OLYMPUS
10.2 Private Equity
10.2.1 Thyrocare Technologies To Raise $51.81 Million From Private Equity Firms
10.3 Venture Financing
10.3.1 ReaMetrix Secures $2.1 Million In Venture Financing
10.4 Equity Offerings
10.4.1 NuSep Completes Private Placement Of $0.76 Million
10.4.2 Starpharma Holdings Completes Private Placement Of Shares For $14.53 Million
10.4.3 Fluorotechnics Announces Rights Issue For $1 Million
10.4.4 Medical Therapies Completes Private Placement Of $0.44 Million
10.5 Debt Offerings
10.5.1 Sonic Healthcare Prices Private Placement Of 5.23% Notes For $95 Million
10.5.2 Sonic Healthcare Prices Private Placement Of 5.73% Notes For $155 Million
10.5.3 HealthLinx Completes First Tranche Private Placement Of Convertible Note For $0.23 Million
10.5.4 Agenix Completes Private Placement Of 10% Convertible Notes For $0.8 Million
10.6 Partnerships
10.6.1 Celera Enters Into Licensing Agreement With Medical Therapies
10.6.2 Rosetta Genomics Enters Into An Agreement With Genetic Technologies
10.6.3 Anteo Diagnostics Enters Into An Agreement With DioSion Diagnostics
10.6.4 IRIS International Enters Into Exclusive Distribution Agreement With Fujirebio
10.6.5 Rosetta Genomics Enters Into Distribution Agreement With Super Religare Laboratories
10.6.6 DxS Signs Cross-Licensing Agreement With Epigenomics
10.6.7 Prodesse Enters Into A licensing Agreement With Abbott Laboratories

11 Recent Developments
11.1 Strategy And Business Planning
11.1.1 Dec 15, 2009: Covance Opens New Clinical Development Offices In South Korea And India, Expands Offices In Japan And Hong Kong
11.1.2 Oct 15, 2009: Tyrian Seeks New Partner Opportunities For Tuberculosis Diagnostic Tests
11.1.3 Sep 08, 2009: Qiagen Inaugurates New Asia Headquarters In Shanghai
11.2 Government and Public Interest
11.2.1 Aug 19, 2009: Quick And Accurate Way Of Diagnosing Endometriosis
11.3 Product News
11.3.1 Jul 20, 2009: Itamar Medical Receives SHONIN Approval For EndoPAT Device
11.3.2 Jul 09, 2009: ZyGEM Announces Availability Of A New Application Note Documenting PrepGEM Bacteria DNA Extraction Kit
11.3.3 Apr 29, 2009: Seegene Launches Seeplex Diarrhea ACE Detection Test
11.3.4 Mar 03, 2009: Seegene Announces The Launch Of Seeplex MTB ACE Detection Test
11.3.5 Feb 23, 2009: Spectral Diagnostics Announces New Data Findings On The Clinical Utility Of EAA At The 13th Annual Critical Care For Endotoxemia Conference

12 Appendix
12.1 Global Markets Direct Research Methodology
12.2 Secondary Research
12.3 Primary Research
12.4 Models
12.5 Forecasts
12.6 Expert Panel Validation
12.7 Currency Conversion
12.8 Contact Us
12.9 Disclaimer

List of Tables:

Table 1: In Vitro Diagnostics, Asia-Pacific, Overall Revenue ($ mn), 2000-2015
Table 2: In Vitro Diagnostics, Asia-Pacific, Cross-Category Analysis, 2000-2015
Table 3: In Vitro Diagnostics, Asia-Pacific, Overall Revenue ($ mn), Historic, 2000-2008
Table 4: In Vitro Diagnostics, Asia-Pacific, Overall Revenue ($ mn), Forecast, 2008-2015
Table 5: In Vitro Diagnostics, Asia-Pacific, Company share by Revenue ($ mn), 2007-2008
Table 6: In Vitro Diagnostics, Japan, Overall Revenue ($ mn), 2000-2015
Table 7: In Vitro Diagnostics, Japan, Overall Revenue ($ mn), Historic, 2000-2008
Table 8: In Vitro Diagnostics, Japan, Overall Revenue ($ mn), Forecast, 2008-2015
Table 9: Clinical Chemistry, Japan, Distribution Share by Revenue ($mn), 2007-2008
Table 10: Genetic Testing, Japan, Distribution Share by Revenue ($mn), 2007-2008
Table 11: Haematology, Japan, Distribution Share by Revenue ($mn), 2007-2008
Table 12: Histology And Cytology, Japan, Distribution Share by Revenue ($mn), 2007-2008
Table 13: Immuno Chemistry, Japan, Distribution Share by Revenue ($mn), 2007-2008
Table 14: Infectious Immunology, Japan, Distribution Share by Revenue ($mn), 2007-2008
Table 15: Microbiology Culture, Japan, Distribution Share by Revenue ($mn), 2007-2008
Table 16: In Vitro Diagnostics, Japan, Company Share by Revenue ($ mn), 2007-2008
Table 17: Clinical Chemistry, Japan, Company Share by Revenue ($ mn), 2007-2008
Table 18: Genetic Testing, Japan, Company Share by Revenue ($ mn), 2007-2008
Table 19: Haematology, Japan, Company Share by Revenue ($ mn), 2007-2008
Table 20: Histology And Cytology, Japan, Company Share by Revenue ($ mn), 2007-2008
Table 21: Immuno Chemistry, Japan, Company Share by Revenue ($ mn), 2007-2008
Table 22: Infectious Immunology, Japan, Company Share by Revenue ($ mn), 2007-2008
Table 23: Microbiology Culture, Japan, Company Share by Revenue ($ mn), 2007-2008
Table 24: In Vitro Diagnostics, Australia, Overall Revenue ($ mn), 2000-2015
Table 25: In Vitro Diagnostics, Australia, Overall Revenue ($ mn), Historic, 2000-2008
Table 26: In Vitro Diagnostics, Australia, Overall Revenue ($ mn), Forecast, 2008-2015
Table 27: Clinical Chemistry, Australia, Distribution Share by Revenue ($mn), 2007-2008
Table 28: Genetic Testing, Australia, Distribution Share by Revenue ($mn), 2007-2008
Table 29: Haematology, Australia, Distribution Share by Revenue ($mn), 2007-2008
Table 30: Histology And Cytology, Australia, Distribution Share by Revenue ($mn), 2007-2008
Table 31: Immuno Chemistry, Australia, Distribution Share by Revenue ($mn), 2007-2008
Table 32: Infectious Immunology, Australia, Distribution Share by Revenue ($mn), 2007-2008
Table 33: Microbiology Culture, Australia, Distribution Share by Revenue ($mn), 2007-2008
Table 34: In Vitro Diagnostics, Australia, Company Share by Revenue ($ mn), 2007-2008
Table 35: Clinical Chemistry, Australia, Company Share by Revenue ($ mn), 2007-2008
Table 36: Genetic Testing, Australia, Company Share by Revenue ($ mn), 2007-2008
Table 37: Haematology, Australia, Company Share by Revenue ($ mn), 2007-2008
Table 38: Histology And Cytology, Australia, Company Share by Revenue ($ mn), 2007-2008
Table 39: Immuno Chemistry, Australia, Company Share by Revenue ($ mn), 2007-2008
Table 40: Infectious Immunology, Australia, Company Share by Revenue ($ mn), 2007-2008
Table 41: Microbiology Culture, Australia, Company Share by Revenue ($ mn), 2007-2008
Table 42: In Vitro Diagnostics, China, Overall Revenue ($ mn), 2000-2015
Table 43: In Vitro Diagnostics, China, Overall Revenue ($ mn), Historic, 2000-2008
Table 44: In Vitro Diagnostics, China, Overall Revenue ($ mn), Forecast, 2008-2015
Table 45: Clinical Chemistry, China, Distribution Share by Revenue ($mn), 2007-2008
Table 46: Genetic Testing, China, Distribution Share by Revenue ($mn), 2007-2008
Table 47: Haematology, China, Distribution Share by Revenue ($mn), 2007-2008
Table 48: Histology And Cytology, China, Distribution Share by Revenue ($mn), 2007-2008
Table 49: Immuno Chemistry, China, Distribution Share by Revenue ($mn), 2007-2008
Table 50: Infectious Immunology, China, Distribution Share by Revenue ($mn), 2007-2008
Table 51: Microbiology Culture, China, Distribution Share by Revenue ($mn), 2007-2008
Table 52: In Vitro Diagnostics, China, Company Share by Revenue ($ mn), 2007-2008
Table 53: Clinical Chemistry, China, Company Share by Revenue ($ mn), 2007-2008
Table 54: Genetic Testing, China, Company Share by Revenue ($ mn), 2007-2008
Table 55: Haematology, China, Company Share by Revenue ($ mn), 2007-2008
Table 56: Histology And Cytology, China, Company Share by Revenue ($ mn), 2007-2008
Table 57: Immuno Chemistry, China, Company Share by Revenue ($ mn), 2007-2008
Table 58: Infectious Immunology, China, Company Share by Revenue ($ mn), 2007-2008
Table 59: Microbiology Culture, China, Company Share by Revenue ($ mn), 2007-2008
Table 60: In Vitro Diagnostics, India, Overall Revenue ($ mn), 2000-2015
Table 61: In Vitro Diagnostics, India, Overall Revenue ($ mn), Historic, 2000-2008
Table 62: In Vitro Diagnostics, India, Overall Revenue ($ mn), Forecast, 2008-2015
Table 63: Clinical Chemistry, India, Distribution Share by Revenue ($mn), 2007-2008
Table 64: Genetic Testing, India, Distribution Share by Revenue ($mn), 2007-2008
Table 65: Haematology, India, Distribution Share by Revenue ($mn), 2007-2008
Table 66: Histology And Cytology, India, Distribution Share by Revenue ($mn), 2007-2008
Table 67: Immuno Chemistry, India, Distribution Share by Revenue ($mn), 2007-2008
Table 68: Infectious Immunology, India, Distribution Share by Revenue ($mn), 2007-2008
Table 69: Microbiology Culture, India, Distribution Share by Revenue ($mn), 2007-2008
Table 70: In Vitro Diagnostics, India, Company Share by Revenue ($ mn), 2007-2008
Table 71: Clinical Chemistry, India, Company Share by Revenue ($ mn), 2007-2008
Table 72: Genetic Testing, India, Company Share by Revenue ($ mn), 2007-2008
Table 73: Haematology, India, Company Share by Revenue ($ mn), 2007-2008
Table 74: Histology And Cytology, India, Company Share by Revenue ($ mn), 2007-2008
Table 75: Immuno Chemistry, India, Company Share by Revenue ($ mn), 2007-2008
Table 76: Infectious Immunology, India, Company Share by Revenue ($ mn), 2007-2008
Table 77: Microbiology Culture, India, Company Share by Revenue ($ mn), 2007-2008
Table 78: Sysmex Corporation Pipeline Products by Equipment Type
Table 79: Sysmex Corporation Pipeline Products By Development Stage
Table 80: Sysmex Corporation Pipeline Products By Therapy Area
Table 81: Qiagen N.V. Pipeline Products by Equipment Type
Table 82: Qiagen N.V. Pipeline Products By Development Stage
Table 83: Qiagen N.V. Pipeline Products By Therapy Area
Table 84: Phadia AB Pipeline Products by Equipment Type
Table 85: Phadia AB Pipeline Products By Development Stage
Table 86: Phadia AB Pipeline Products By Therapy Area
Table 87: Ortho-Clinical Diagnostics Inc. Pipeline Products by Equipment Type
Table 88: Ortho-Clinical Diagnostics Inc. Pipeline Products By Development Stage
Table 89: Ortho-Clinical Diagnostics Inc. Pipeline Products By Therapy Area
Table 90: Ortho-Clinical Diagnostics Inc. Pipeline Products By Clinical Trials
Table 91: Mindray Medical International Limited Pipeline Products by Equipment Type
Table 92: Mindray Medical International Limited Pipeline Products By Therapy Area
Table 93: Hologic, Inc. Pipeline Products by Equipment Type
Table 94: Hologic, Inc. Pipeline Products By Therapy Area
Table 95: Gen-Probe Incorporated Pipeline Products by Equipment Type
Table 96: Gen-Probe Incorporated Pipeline Products By Development Stage
Table 97: Gen-Probe Incorporated Pipeline Products By Therapy Area
Table 98: Gen-Probe Incorporated Pipeline Products By Clinical Trials
Table 99: DiaSorin S.p.A Pipeline Products by Equipment Type
Table 100: DiaSorin S.p.A Pipeline Products By Development Stage
Table 101: DiaSorin S.p.A Pipeline Products By Therapy Area
Table 102: Biomerieux Sa Pipeline Products by Equipment Type
Table 103: Biomerieux Sa Pipeline Products By Development Stage
Table 104: Biomerieux Sa Pipeline Products By Therapy Area
Table 105: Biomerieux Sa Pipeline Products By Clinical Trials
Table 106: Becton, Dickinson and Company Pipeline Products by Equipment Type
Table 107: Becton, Dickinson and Company Pipeline Products By Development Stage
Table 108: Becton, Dickinson and Company Pipeline Products By Therapy Area
Table 109: Becton, Dickinson and Company Pipeline Products By Clinical Trials
Table 110: Beckman Coulter, Inc. Pipeline Products by Equipment Type
Table 111: Beckman Coulter, Inc. Pipeline Products By Development Stage
Table 112: Beckman Coulter, Inc. Pipeline Products By Therapy Area
Table 113: Abbott Laboratories Pipeline Products by Equipment Type
Table 114: Abbott Laboratories Pipeline Products By Development Stage
Table 115: Abbott Laboratories Pipeline Products By Therapy Area
Table 116: Eiken Chemical Co.,Ltd. Pipeline Products by Equipment Type
Table 117: Eiken Chemical Co.,Ltd. Pipeline Products By Development Stage
Table 118: Eiken Chemical Co.,Ltd. Pipeline Products By Therapy Area
Table 119: Metropolis Health Services Plans To Acquire Diagnostic Labs
Table 120: PerkinElmer Completes Acquisition Of Sym-Bio LifeScience
Table 121: PerkinElmer Acquires Surendra Genetic Labs
Table 122: Beckman Coulter Completes Acquisition Of Olympus-DS From OLYMPUS
Table 123: Thyrocare Technologies To Raise $51.81 Million From Private Equity Firms
Table 124: ReaMetrix Secures $2.1 Million In Venture Financing
Table 125: NuSep Completes Private Placement Of $0.76 Million
Table 126: Starpharma Holdings Completes Private Placement Of Shares For $14.53 Million
Table 127: Fluorotechnics Announces Rights Issue For $1 Million
Table 128: Medical Therapies Completes Private Placement Of $0.44 Million
Table 129: Sonic Healthcare Prices Private Placement Of 5.23% Notes For $95 Million
Table 130: Sonic Healthcare Prices Private Placement Of 5.73% Notes For $155 Million
Table 131: HealthLinx Completes First Tranche Private Placement Of Convertible Note For $0.23 Million
Table 132: Agenix Completes Private Placement Of 10% Convertible Notes For $0.8 Million
Table 133: Celera Enters Into Licensing Agreement With Medical Therapies
Table 134: Rosetta Genomics Enters Into An Agreement With Genetic Technologies
Table 135: Anteo Diagnostics Enters Into An Agreement With DioSion Diagnostics
Table 136: IRIS International Enters Into Exclusive Distribution Agreement With Fujirebio
Table 137: Rosetta Genomics Enters Into Distribution Agreement With Super Religare Laboratories
Table 138: DxS Signs Cross-Licensing Agreement With Epigenomics
Table 139: Prodesse Enters Into A licensing Agreement With Abbott Laboratories
Table 140: USD to Local Currency, Average Exchange Rate 2008

List of Figures:

Figure 1: In Vitro Diagnostics, Asia-Pacific, Overall Revenue ($ mn), 2000-2015
Figure 2: In Vitro Diagnostics, Asia-Pacific, Cross-Category Analysis, 2000-2015
Figure 3: In Vitro Diagnostics, Asia-Pacific, Overall Revenue ($ mn), Historic, 2000-2008
Figure 4: In Vitro Diagnostics, Asia-Pacific, Overall Revenue ($ mn), Forecast, 2008-2015
Figure 5: In Vitro Diagnostics, Asia-Pacific, Company share (%), 2008
Figure 6: In Vitro Diagnostics, Japan, Overall Revenue ($ mn), 2000-2015
Figure 7: In Vitro Diagnostics, Japan, Overall Revenue ($ mn), Historic, 2000-2008
Figure 8: In Vitro Diagnostics, Japan, Overall Revenue ($ mn), Forecast, 2008-2015
Figure 9: In Vitro Diagnostics, Japan, Company Share (%), 2008
Figure 10: Clinical Chemistry, Japan, Company Share (%), 2008
Figure 11: Genetic Testing, Japan, Company Share (%), 2008
Figure 12: Haematology, Japan, Company Share (%), 2008
Figure 13: Histology And Cytology, Japan, Company Share (%), 2008
Figure 14: Immuno Chemistry, Japan, Company Share (%), 2008
Figure 15: Infectious Immunology, Japan, Company Share (%), 2008
Figure 16: Microbiology Culture, Japan, Company Share (%), 2008
Figure 17: In Vitro Diagnostics, Australia, Overall Revenue ($ mn), 2000-2015
Figure 18: In Vitro Diagnostics, Australia, Overall Revenue ($ mn), Historic, 2000-2008
Figure 19: In Vitro Diagnostics, Australia, Overall Revenue ($ mn), Forecast, 2008-2015
Figure 20: In Vitro Diagnostics, Australia, Company Share (%), 2008
Figure 21: Clinical Chemistry, Australia, Company Share (%), 2008
Figure 22: Genetic Testing, Australia, Company Share (%), 2008
Figure 23: Haematology, Australia, Company Share (%), 2008
Figure 24: Histology And Cytology, Australia, Company Share (%), 2008
Figure 25: Immuno Chemistry, Australia, Company Share (%), 2008
Figure 26: Infectious Immunology, Australia, Company Share (%), 2008
Figure 27: Microbiology Culture, Australia, Company Share (%), 2008
Figure 28: In Vitro Diagnostics, China, Overall Revenue ($ mn), 2000-2015
Figure 29: In Vitro Diagnostics, China, Overall Revenue ($ mn), Historic, 2000-2008
Figure 30: In Vitro Diagnostics, China, Overall Revenue ($ mn), Forecast, 2008-2015
Figure 31: In Vitro Diagnostics, China, Company Share (%), 2008
Figure 32: Clinical Chemistry, China, Company Share (%), 2008
Figure 33: Genetic Testing, China, Company Share (%), 2008
Figure 34: Haematology, China, Company Share (%), 2008
Figure 35: Histology And Cytology, China, Company Share (%), 2008
Figure 36: Immuno Chemistry, China, Company Share (%), 2008
Figure 37: Infectious Immunology, China, Company Share (%), 2008
Figure 38: Microbiology Culture, China, Company Share (%), 2008
Figure 39: In Vitro Diagnostics, India, Overall Revenue ($ mn), 2000-2015
Figure 40: In Vitro Diagnostics, India, Overall Revenue ($ mn), Historic, 2000-2008
Figure 41: In Vitro Diagnostics, India, Overall Revenue ($ mn), Forecast, 2008-2015
Figure 42: In Vitro Diagnostics, India, Company Share (%), 2008
Figure 43: Clinical Chemistry, India, Company Share (%), 2008
Figure 44: Genetic Testing, India, Company Share (%), 2008
Figure 45: Haematology, India, Company Share (%), 2008
Figure 46: Histology And Cytology, India, Company Share (%), 2008
Figure 47: Immuno Chemistry, India, Company Share (%), 2008
Figure 48: Infectious Immunology, India, Company Share (%), 2008
Figure 49: Microbiology Culture, India, Company Share (%), 2008
Figure 50: Global Markets Direct Methodology

Note: Product cover images may vary from those shown

- Sysmex Corporation
- Siemens Healthcare
- Qiagen N.V.
- Phadia AB
- Ortho-Clinical Diagnostics Inc.
- Mindray Medical International Limited
- Hologic, Inc.
- Gen-Probe Incorporated
- F. Hoffmann-La Roche Ltd.
- Digene Corporation
- DiaSorin S.p.A
- Dade Behring Holdings, Inc.
- Bio-Rad Laboratories, Inc.
- bioMerieux S.A.
- Becton, Dickinson and Company
- Beckman Coulter, Inc.
- Abbott Laboratories
- Eiken Chemical Co.,Ltd.
- Advanced Life Science Institute, Inc.

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos